ArticleFrontiers in cardiovascular medicine2026
Pak1 overexpression is associated with mild concentric cardiac remodeling and favorable systolic and diastolic functional indices in transgenic mice.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: p21-activated kinase 1 (Pak1) is a serine/threonine kinase implicated in cardioprotection, calcium handling, and excitation-contraction coupling. However, the effects of Pak1 gain- and loss-of-function on cardiac performance remain incompletely understood. Here, we characterized baseline overall cardiac performance in cardiac-specific Pak1 transgenic (TG) and knockout (KO) mice using advanced echocardiography and invasive hemodynamic assessments. Methods: Adult wild type (WT), Pak1 TG, and Pak1 KO mice, aged 7-11 months, underwent comprehensive phenotyping, including M-mode echocardiography, pulsed-wave and tissue Doppler imaging, speckle-tracking echocardiography (STE)-based strain analysis, invasive left ventricular pressure measurements, Western blot analysis, and histological evaluation using hematoxylin and eosin and Masson's trichrome staining. In addition, WT and Pak1 TG mice aged 20-22 months were studied to assess persistence of the TG phenotype with aging. Results: M-mode echocardiography showed that Pak1 TG mice exhibited concentric LV remodeling, characterized by increased wall thickness and reduced chamber dimensions compared with KO and WT controls. Histological analysis revealed greater cardiomyocyte cross-sectional area and width in TG mice than in KO mice, whereas WT values were intermediate and did not differ significantly from TG. Masson's trichrome staining detected no significant difference in myocardial fibrosis between TG and WT hearts under the present sampling conditions. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) expression was not elevated in TG hearts. TG hearts exhibited higher fractional shortening and increased global longitudinal, radial, and circumferential strain, indicating increased echocardiographic indices of systolic function. Invasive hemodynamics showed higher + Conclusions: Pak1 overexpression is associated with concentric LV remodeling and favorable systolic and diastolic functional indices. These findings support further investigation of Pak1-dependent mechanisms and its role in cardiac disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.